NCT02939859 - Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions | Biotech Hunter

Timeline

Start Date

December 15, 2018

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2023

Conditions

Multiple SclerosisAutoimmune

Interventions

PROCEDURE

Microcannula Harvest Adipose

Use of Closed Syringe Microcannula Harvest Autologous Adipose-Derived Stem/Stromal Cells

DEVICE

Centricyte 1000

Use of Centricyte 1000 closed system digestion adipose tissue stromal vascular fraction to create a AD-cSVF

PROCEDURE

Sterile Normal Saline IV deployment AD-cSVF

Sterile Normal Saline Suspension AD-cSVF in 500 cc IV use

Trial Locations (2)

Regenevita LLC, Stevensville

Global Alliance for Regenerative Medicine (GARM), Roatán